Skip to main content

Table 1 Clinical characteristics and first-line treatment modalities

From: Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

  No. of patients (%)
n = 75 (100)
Median age [range], years 54 [16–83]
Sex
 Men
 Women
51 (68)
24 (32)
Ann Arbor stage
 IE-IIE
 IIIE-IVE
 B symptoms
34 (45)
41 (55)
26 (35)
LDH
 Elevated
 Normal
 Missing
41 (56)
32 (44)
2
ECOG
 0–1
  > 1
 Missing
50 (72)
19 (28)
6
No. of extranodal sites
 1
 2
 3
  > 3
24 (32)
30 (40)
13 (17)
8 (11)
Calcium
 Elevated
 Normal
 Missing
6 (9)
62 (91)
7
AP
 Elevated
 Normal
 Missing
14 (22)
50 (78)
11
Skeletal involvement
 Unifocal
 Multifocal
45 (60)
30 (40)
Chemotherapy
 Palliative
 CHOP
 more intensive than CHOP
2 (3)
46 (61)
27 (36)
Rituximab 60 (80)
Radiotherapy 37 (49)
CNS treatment 20 (27)
Autologous transplantation 6 (8)